Intracellular drug delivery in Leishmania-infected macrophages: Evaluation of saponin-loaded PLGA nanoparticles

Abstract

Drug delivery systems present an opportunity to potentiate the therapeutic effect of antileishmanial drugs. Colloidal carriers are rapidly cleared by the phagocytic cells of the reticuloendothelial system (RES), rendering them ideal vehicles for passive targeting of antileishmanials. This paper describes the development of poly(D,L-lactide-co-glycolide) (PLGA) nanoparticles (NPs) for the antileishmanial saponin β-aescin. NPs were prepared using the combined emulsification solvent evaporation/salting-out technique. Confocal microscopy was used to visualise the internalisation and intracellular trafficking of fluorescein- and nile red-labelled PLGA NPs in J774A.1 macrophages infected with GFP-transfected Leishmania donovani. The in vitro activity of aescin and aescin-loaded NPs on L. infantum was determined in the axenic model as well as in the ex vivo model. The developed PLGA NPs were monodispersed with Z_ave<300 nm, exhibited negative zeta potentials and had relatively high drug loadings ranging from 5.80 to 8.68% w/w PLGA. The fluorescent NPs were internalised by the macrophages and trafficked towards the lysosomes after 2 h in vitro incubation. Co-localisation of the NPs and the parasite was not shown. A two-fold increase in activity was observed in the ex vivo macrophage model by encapsulating β-aescin in PLGA NPs (IC₅₀, 0.48–0.76 µg/mL vs. 1.55 ± 0.32 µg/mL for the free drug).

Keywords::

• Leishmaniasis
• J774A.1 macrophages
• PLGA nanoparticles
• saponins
• simplex mixture design
• co-localisation
• GFP-transfected L. donovani

Acknowledgements

The assistance of Karen Hoefkens for the preparation and physical characterisation of the PLGA NPs is greatly appreciated. Prof. Dr. Pieter Van der Veken is acknowledged for the synthesis of the fluorescein-PLGA conjugate.

Declaration of interest

The authors report no declarations of interest.